Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,758,238
+$2,134,975 QoQ
Shares Held
7,302
+1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,336
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. LLY ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
|
24,805 | $597,304 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,758,238 | 7,302 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,623,263 | 7,201 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,182,087 | 6,683 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,720,443 | 15,361 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,240,043 | 14,419 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $11,001,947 | 13,321 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $10,052,984 | 13,022 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $11,733,389 | 13,244 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $11,777,183 | 13,008 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $9,599,248 | 12,339 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $6,830,073 | 11,717 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $2,779,110 | 5,174 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,901,713 | 4,055 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,509,674 | 4,396 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,895,782 | 5,182 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,338,345 | 4,139 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,271,630 | 3,922 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,046,968 | 3,656 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,089,135 | 3,943 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $641,625 | 2,777 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $517,108 | 2,253 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $294,988 | 1,579 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $249,883 | 1,480 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $262,439 | 1,773 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $259,076 | 1,578 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $277,856 | 2,003 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||